Wolverine Trading’s Corcept Therapeutics CORT Stock Holding History

Wolverine Trading’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$709K	Sell	8,448 -291	-3%	-$21.1K	﹤0.01%	3292
2025 Q2	$640K	Buy	+8,739	New	+$634K	﹤0.01%	2713
2022 Q4	–	Sell	-11,994	Closed	-$306K	–	4135
2022 Q3	$306K	Buy	+11,994	New	+$321K	﹤0.01%	3131
2020 Q4	–	Sell	-16,903	Closed	-$297K	–	4876
2020 Q3	$297K	Sell	16,903 -4,526	-21%	-$72.1K	﹤0.01%	3409
2020 Q2	$359K	Buy	21,429 +10,225	+91%	+$144K	﹤0.01%	3109
2020 Q1	$131K	Buy	+11,204	New	+$139K	﹤0.01%	3897
2019 Q1	–	Sell	-13,112	Closed	-$163K	–	4611
2018 Q4	$171K	Sell	13,112 -33,691	-72%	-$445K	﹤0.01%	3780
2018 Q3	$656K	Buy	+46,803	New	+$654K	﹤0.01%	2787
2017 Q3	–	Sell	-15,827	Closed	-$236K	–	4478
2017 Q2	$189K	Buy	+15,827	New	+$172K	﹤0.01%	3630

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wolverine Trading's CORT Position: Q3 2025 in Review

Wolverine Trading reduced its Corcept Therapeutics (CORT) stake by 3.3% in Q3 2025, selling an estimated $21.1K and leaving 8,448 shares worth $709K. The position accounts for ﹤0.01% of the portfolio, ranked #3292.

Wolverine Trading first reported a position in CORT in Q2 2017 and has held it in 9 quarters since. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

Wolverine Trading held 8,448 shares of Corcept Therapeutics worth $709K as of Q3 2025.
Wolverine Trading sold 291 Corcept Therapeutics shares in Q3 2025, an estimated $21.1K.
Corcept Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3292 holding.
Wolverine Trading first reported a position in Corcept Therapeutics in Q2 2017 and has held it in 9 quarters since.
429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.